Allogene Therapeutics IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 1.97 USD | 4,46 USD | 0,984 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 9 USD | 8 | 4 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 345.154.561 | 19,15 | 5,59 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Allogene Therapeutics Inc
Mitarbeiter 150
Handelsplatz NASDAQ
Ticker Symbol ALLO
IPO Datum 2018-10-11
Adresse 210 East Grand Avenue, South San Francisco, CA, United States, 94080
Webseite https://allogene.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Arie S. Belldegrun F.A.C.S., M.D. | Co-Founder & Executive Chairman |
| 2 | Dr. Zachary J. Roberts M.D., Ph.D. | President, CEO & Director |
| 3 | Mr. Joshua A. Kazam | Co-Founder & Director |
| 4 | Dr. David D. Chang M.D., Ph.D. | Co-Founder & Director |
| 5 | Mr. Geoffrey M. Parker | Executive VP & CFO |
| 6 | Mr. Benjamin M. Beneski | Senior VP & Chief Technical Officer |
| 7 | Mr. Earl M. Douglas Esq. | Senior VP, General Counsel, Compliance Officer & Corporate Secretary |
| 8 | Ms. Susan R. Lundeen | Chief People Officer |
| 9 | Ms. Christine Cassiano | Executive VP, Chief Corporate Affairs & Brand Strategy Officer |
| 10 | Ms. Annie Yoshiyama | SVP & Corporate Controller |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Pfizer Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | TPG GP A, LLC | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 6 | PRIMECAP Management Company | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 9 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 10 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 11 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Frazier Life Sciences Management, L.P. | 0,00% | 0,00 Mio. USD |
| 13 | Woodline Partners LP | 0,00% | 0,00 Mio. USD |
| 14 | Patient Square Capital LP | 0,00% | 0,00 Mio. USD |
| 15 | Marshall Wace Asset Management Ltd | 0,00% | 0,00 Mio. USD |
| 16 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 17 | Candriam Luxembourg S.C.A. | 0,00% | 0,00 Mio. USD |
| 18 | Wildcat Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 19 | Two Sigma Advisers, LLC | 0,00% | 0,00 Mio. USD |
| 20 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |